臨床試驗

Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery

NCT：NCT07343596 · RECRUITING

NCT IDNCT07343596

狀態RECRUITING

開始日期2026-04-15

SponsorUniversity of Wisconsin, Madison (OTHER)

First posted2026-01-15

Last updated2026-09-16

簡要摘要

The goal of this clinical trial is to study whether researchers can create a patient-specific tumor system, called a culture vessel, in a timely manner and determine if it can predict how someone will respond to a specific therapy. Participants will: * Undergo a research biopsy * Take pembrolizumab per standard of care prior to surgery

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。